SHH · 600664.SS
Harbin Pharmaceutical Group Co., Ltd.
CN¥5.55+CN¥0.26 (+4.91%)
Harbin Pharmaceutical Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 43.71% below the high.
Loading market information…
SHH · 600789.SS · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 03:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Shandong Lukang Pharmaceutical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 37.01% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Shandong Lukang Pharmaceutical Co.,Ltd.’s forward annual dividend is CN¥0.05 per share, paid annual. The forward yield is 0.73% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Shandong Lukang Pharmaceutical Co.,Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Shandong Lukang Pharmaceutical Co.,Ltd., a Chinese enterprise, primarily focuses on the production and distribution of bio-pharmaceuticals and antibiotics. Their comprehensive product range features active pharmaceutical ingredients (APIs) and finished drug formulations for both human and veterinary use, alongside bio-pesticides, traditional herbal remedies, and amino acids. Beyond its core pharmaceutical operations, the company also engages in environmental management services, including wastewater treatment, odor control, and the maintenance of sewage facilities, as well as the manufacturing and sale of ecological protection materials. Established in 1966 as Jining Antibiotic Factory, the firm rebranded to its current name in October 1993. Headquartered in Jining, China, it maintains a global footprint, distributing its offerings to approximately 40 nations across Asia, Europe, Africa, and the United States.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:11 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥5.55+CN¥0.26 (+4.91%)
Harbin Pharmaceutical Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 43.71% below the high.
CN¥45.96+CN¥3.26 (+7.63%)
PharmaBlock Sciences (Nanjing), Inc.’s quoted price sits in the upper half of its reported 52-week range, 20.14% below the high.
CN¥8.93+CN¥0.07 (+0.79%)
Zhejiang Xianju Pharmaceutical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 11.14% below the high.
CN¥16.52+CN¥0.31 (+1.91%)
Tianjin Ringpu Bio-Technology Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 24.25% below the high.
CN¥8.23+CN¥0.16 (+1.98%)
Jiuzhitang Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 24.08% below the high.
CN¥20.24+CN¥0.19 (+0.95%)
Zhejiang Tianyu Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 27.19% below the high.
CN¥5.04+CN¥0.06 (+1.2%)
Renhe Pharmacy Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 21.37% below the high.
CN¥10.92+CN¥0.21 (+1.96%)
Sichuan Huiyu Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 36.99% below the high.
